FindTrial
Sign In

Research on optimizing the diagnosis and treatment strategy for metabolic disorders in PCOS patients based on IR

Research on optimizing the diagnosis and treatment strategy for metabolic disorders in Ppolycystic ovary syndrome patients based on insulin resistance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010682
Enrollment
Unknown
Registered
2017-02-19
Start date
2017-02-19
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

traditional intervention:traditional intervention
Insulin sensitizer:Insulin sensitizer

Sponsors

Renji Hospital, Shanghai Jiaotong University, School of Medicne
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: PCOS patients (according to the 2003 Rotterdam diagnostic criteria) aged 18-45 years, nearly three months without the use of insulin-sensitive drugs, did not participate in any other clinical research, and have no other reasons are not suitable for clinical trials. Exclude pregnancy, heart and liver function is normal.

Exclusion criteria

Exclusion criteria: Patients with severe liver and kidney dysfunction, heart failure, leukopenia, platelet or hemoglobin abnormalities and drug allergy similar to the chemical structure of the test drug, history of venous thrombosis, history of cancer, severe gastrointestinal function, Diet pills, glucocorticoids, transplanted drugs or any clinical research drug.

Design outcomes

Primary

MeasureTime frame
Lipid metabolism;Glucose metabolism;—

Countries

China

Contacts

Public ContactTao Tao

Renji Hospital, Shanghai Jiaotong University, School of Medicne

taotaozhen@hotmail.com+86 13817701776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026